Idan Elmelech, MA, MBA
Chief Operating Officer
Idan joined BridgeBio Pharma in July 2023, led the spinout of BBOT as an independent private entity, and currently serves as Chief Operating Officer. Prior to BridgeBio, Idan spent time in early-stage biotech venture capital as well as management consulting for biopharma companies.
Idan holds an MBA from Columbia Business School and an MA, Biotechnology from Columbia Graduate School of Arts and Sciences.